Please login to the form below

Not currently logged in
Email:
Password:

Bo Jesper Hansen to step down as chairman of Sobi

Håkan Björklund will be nominated as his replacement

Sobi's Bo Jesper Hansen is to step down as chairman of the board, a role he has held since the merger of Biovitrum and Swedish Orphan International in 2010.

Hansen joined Swedish Orphan International AB in 1993 and served as its chief executive officer between 1998 and 2010. He has also been a medical advisor to Pfizer, Pharmacia and Yanaouchi and founded Scandinavian Medical Research.

In a statement, Sobi credited Hansen with growing the specialty healthcare company into an “international pioneer in rare diseases with a strong commercial footprint across Europe, North America, the Middle East and Russia”.

Hansen's proposed replacement is Håkan Björklund, who currently serves as private equity firm Avista Capital Partners' healthcare industry executive.

Björklund served as chief executive officer at Nycomed until 2011 and oversaw its growth from a largely Scandinavian business into a global pharmaceutical company operating across Europe, Latin America and Russia.

He has also served as a member of several firms' board of directors, including Alere, Coloplast, Danisco, Lundbeck and Biovitrum.

Björklund's appointment as chairman will be announced after the company's annual shareholder meeting later this year.

2nd March 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics